Digital Phenotyping for Retinal Disease - Takeaways - MDSpire

Digital Phenotyping for Retinal Disease

Can your smartphone reveal how you're really coping with vision loss?

  • July 24, 2026

  • 3 min

Share

  • 1

    A pilot study evaluated the feasibility of digital phenotyping for patients with inherited retinal diseases using the OverSight app.

  • 2

    The study enrolled 25 patients with retinitis pigmentosa and choroideremia, following them for 12 months.

  • 3

    Participants generated a median of 6,087 steps per day, with older individuals typing significantly slower than younger ones.

  • 4

    Completion rates for patient-reported outcome measures exceeded 70 percent, indicating strong engagement with the app.

  • 5

    The study suggests that digital phenotyping could complement traditional assessments by capturing real-world behavioral changes.

Original Source(s)

Digital Phenotyping for Retinal Disease

  • July 24, 2026

Related Content

Expanding Optogenetics to Geographic Atrophy

Jordi Monés, MD, PhD, discusses the rationale for evaluating MCO-010 (sonpiretigene isteparvovec) in GA following encouraging findings in retinitis pigmentosa and Stargardt disease.

Lessons From the ARCHER Trial

Margaret A. Chang, MD, MS, discusses how findings from the phase 2 ARCHER trial informed the design of the ongoing phase 3 ARCHER II study of vonaprument, which is expected to read out later this year.

A Novel Technique for Uveitis

Dr. David Chin Yee describes the benefits of delivering XIPERE directly into the suprachoroidal space